Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,8411,860 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Cultural and Linguistic Adaptation of a Breast Reconstruction Decision Tool
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Breast reconstruction is a critical component of breast cancer treatment because it restores quality of life and body image after mastectomy. It has become...

$2.18M
USD
Active NON-SBIR/STTR RPGS
Fecal microbial transplantation for chemotherapy behavioral side effects
NATIONAL CANCER INSTITUTE Ohio State University United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Mental side effects of chemotherapy reduce quality of life and treatment dosing, thereby increasing mortality. Current supportive care treatments are ineff...

$6.15M
USD
Completed OTHER RESEARCH-RELATED
Elucidating the role of hepatic ketogenesis in pancreatic cancer cachexia and recovery
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT 80% of patients with Pancreatic Ductal Adenocarcinoma (PDAC) develop cachexia, which results in dispropor- tionate skeletal muscle mass loss, relative to c...

$1.18M
USD
Completed OTHER RESEARCH-RELATED
Dissecting the Role of Germline Genetics in RAS-Driven Cancers
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Most applications of genomics in modern oncology focus on somatic mutations acquired during tumor evolution and selecting drugs to target these tumor-speci...

$1.64M
USD
Active NON-SBIR/STTR RPGS
Investigating the Roles of Pregnane X Receptor in Human Breast Cancers
NATIONAL CANCER INSTITUTE Kansas City University United States 2024 – 2027

Project Summary/Abstract Breast cancer is the second most common type of cancer diagnosed worldwide and is also the second leading cause of cancer-related deaths among women overal...

$4.2M
USD
Completed OTHER RESEARCH-RELATED
A multi-omics approach to evaluate the role of chronic inflammation in breast cancer development
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2024 – 2026

Project Summary The long-term objective of this project is to develop Dr. Romanos-Nanclares’s capacity to conduct studies that integrate dietary and lifestyle factors with multi-om...

$1.69M
USD
Active NON-SBIR/STTR RPGS
Understanding and improving novel oncolytic viruses for pancreatic cancer
NATIONAL CANCER INSTITUTE University of North Carolina Charlotte United States 2024 – 2027

PROJECT SUMMARY/ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a poor prognosis and accounts for upwards of 95% of all pancreatic cancers. With the...

$4.49M
USD
Completed OTHER RESEARCH-RELATED
Influence of Social Determinants of Health and Epigenomics on Psychological Symptom Cluster Severity
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT The psychological symptom cluster is a common problem that impacts women receiving breast cancer treatment and is associated with several negative outcomes...

$1.62M
USD
Active OTHER RESEARCH-RELATED
Building equity in cancer screening through research: The Siteman Catchment CSRN Hub
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2027

To bring equity principles to research and practice of cancer screening and early detection, we will build a CSRN ACCESS Hub at Siteman Cancer Center. Improving early detection is...

$8.75M
USD
Completed OTHER RESEARCH-RELATED
A Chemoproteomic Approach to Identify Molecular Glues for Targeted Cancer Therapy
NATIONAL CANCER INSTITUTE Broad Institute, Inc United States 2024 – 2026

Project Summary / Abstract Research Plan: Targeted protein degradation using molecular glues - small molecules that bring a protein of interest in proximity to an E3 ligase - emerg...

$1.71M
USD
Active OTHER RESEARCH-RELATED
HFH-MSU CSRN ACCrual Enrollment and Screening Site
NATIONAL CANCER INSTITUTE Henry Ford Health + Michigan State Unive... United States 2024 – 2027

Metropolitan-Detroit based Henry Ford Health (HFH) has over 20-years of experience in the successful conduct of multi-site cancer screening and prevention clinical trials research....

$8.65M
USD
Active NON-SBIR/STTR RPGS
New Chemical Tools for Covalent Drug Discovery
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2027

ABSTRACT Development of covalent drugs for cancer therapy relies heavily on identifying the full spectrum of on- and off- targets within the proteome, along with the specific site...

$2.5M
USD
Completed OTHER RESEARCH-RELATED
Harnessing Exercise to Enhance Immunity and Boost Immunotherapy Outcomes in Patients with Lung Cancer
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2026

PROJECT SUMMARY Overview: 1.8 million people die of lung cancer each year across the globe. Immunotherapy, particularly using immune checkpoint inhibitors (ICIs), has revolutionize...

$1.63M
USD
Active NON-SBIR/STTR RPGS
Urology practice consolidation and care for men with prostate cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

PROJECT SUMMARY Management of prostate cancer remains a daunting challenge. Many men with prostate cancer will not die from it—even without any intervention—either due to competing...

$5.93M
USD
Completed OTHER RESEARCH-RELATED
Cancer Neuroscience - An Emerging Hallmark
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2025

ABSTRACT Accelerated understanding of nervous system functions and cancer has led to cancer neuroscience evolving into a new frontier of discovery in cancer biology and therapy. Th...

$150K
USD
Active NON-SBIR/STTR RPGS
Expanding access to colorectal cancer screening through community pharmacies: The PharmFIT study
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2024 – 2029

Project Abstract (Summary) Medically underserved populations are disproportionately affected by screen-preventable cancers, such as colorectal cancer (CRC). Entities such as the Un...

$6.67M
USD
Active TRAINING, INDIVIDUAL
Determining the Role of SOX8 in Myogenesis and Rhabdomyosarcomagenesis
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital Gr... United States 2024 – 2027

Project Summary/Abstract Rhabdomyosarcoma (RMS) is a common aggressive pediatric soft tissue sarcoma. Despite many rigorous clinical trials, the survival rate for high-risk patient...

$479.7K
USD
Completed TRAINING, INDIVIDUAL
Identifying the Mechanism of Resistance to Immunotherapy in Merkel Cell Carcinoma (for Zachary Reinstein)
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2024 – 2026

Project Summary/Abstract Merkel cell carcinoma (MCC) is the most aggressive and fatal cancer on a case-by-case basis with rapidly rising incidence. Approximately 80% of MCC cases a...

$441.9K
USD
Completed TRAINING, INDIVIDUAL
Intraoperative Molecular Imaging of Metastatic Osteosarcoma with 111In-dinutuximab-IR800
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2024 – 2026

Intraoperative identification of metastatic lesions is challenging due to unpredictable locations and coverage by normal tissue. Intraoperative molecular imaging (IMI) uses targete...

$813.4K
USD
Completed OTHER RESEARCH-RELATED
Translation Rewiring Underlines Drug Resistance to Lethal Targeted Ribosome Biogenesis Therapeutics in Cancer
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2026

Project Summary/Abstract Increased ribosome biogenesis is a hallmark of cancer and reflects the increased and pervasive protein synthetic needs of the cancer cells. Targeting this...

$1.09M
USD